• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻早期子宫内膜腺癌患者的保留生育力治疗:病例系列研究。

Fertility sparing treatment in young patients with early endometrial adenocarcinoma: case series.

机构信息

Mehri Jafari Shobeiri, Associate Professor, Department of Gynecologic Oncology, Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Parvin Mostafa Gharabaghi, Associate Professor, Department of Gynecologic Oncology, Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Pak J Med Sci. 2013 Apr;29(2):651-5. doi: 10.12669/pjms.292.3280.

DOI:10.12669/pjms.292.3280
PMID:24353597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3809239/
Abstract

OBJECTIVE

The aim of this study was to evaluate fertility-sparing therapy in young patients with endometrial carcinoma.

METHODOLOGY

This prospective study was carried out on 8 patients with clinical and radio-graphic stage IA, well differentiated endometrioid adenocarcinoma of the endometrium in Alzahra hospital, Tabriz, Iran. Treatment comprised high-dose megestrol acetate. Dilatation and curettage was repeated every three months.

RESULTS

The mean age of the patients was 30 (SD,3.21) years (range 24-35). Of the 8 patients, 7 (87.5%) achieved complete response. The mean time to response was 6.5 months (range 3-9). Of the complete responders, 3 of 7(42.8%) had recurrence; one patient underwent immediate hysterectomy, and 2 were successfully treated with second-line therapy and both subsequently conceived. Conception occurred in 3 of 7 patients (42.8%), in two more than once, However successful pregnancy occurred only in two patients. One patient developed Concomitant ovarian adenocarcinoma.

CONCLUSIONS

High dose progestin therapy can be an effective fertility-sparing treatment in young patients with well differentiated stage IA endometrial endometrioid cancer confined to endometrium. However, close follow up is required because of risks of conservative treatment.

摘要

目的

本研究旨在评估子宫内膜癌年轻患者的保留生育功能治疗。

方法

这项前瞻性研究在伊朗大不里士 Alzahra 医院对 8 名患有临床和影像学 IA 期、分化良好的子宫内膜内异腺癌的患者进行。治疗包括大剂量甲地孕酮。刮宫每 3 个月重复一次。

结果

患者的平均年龄为 30 岁(标准差为 3.21)(范围为 24-35)。8 名患者中,7 名(87.5%)完全缓解。达到缓解的平均时间为 6.5 个月(范围为 3-9)。在完全缓解者中,7 名中的 3 名(42.8%)复发;1 名患者立即接受了子宫切除术,2 名患者成功接受了二线治疗,随后均成功怀孕。7 名患者中有 3 名(42.8%)怀孕,其中 2 名不止一次怀孕,但只有 2 名成功怀孕。1 名患者并发卵巢腺癌。

结论

对于局限于子宫内膜的分化良好的 IA 期子宫内膜内异腺癌年轻患者,大剂量孕激素治疗可以是一种有效的保留生育功能治疗方法。然而,由于保守治疗的风险,需要密切随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5328/3809239/69c6d3593d8b/pjms-29-651-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5328/3809239/69c6d3593d8b/pjms-29-651-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5328/3809239/69c6d3593d8b/pjms-29-651-g001.jpg

相似文献

1
Fertility sparing treatment in young patients with early endometrial adenocarcinoma: case series.年轻早期子宫内膜腺癌患者的保留生育力治疗:病例系列研究。
Pak J Med Sci. 2013 Apr;29(2):651-5. doi: 10.12669/pjms.292.3280.
2
Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.孕激素治疗在成功使用孕激素进行保留生育功能治疗后复发的子宫内膜腺癌患者中的应用。
Gynecol Oncol. 2013 Apr;129(1):7-11. doi: 10.1016/j.ygyno.2012.12.037. Epub 2012 Dec 30.
3
The role of prolonged progestin treatment and factors predicting successful fertility-sparing treatment for early endometrial endometrioid adenocarcinoma.孕激素延长治疗的作用和预测早期子宫内膜样腺癌保留生育功能治疗成功的因素。
Eur J Obstet Gynecol Reprod Biol. 2021 Dec;267:99-104. doi: 10.1016/j.ejogrb.2021.10.026. Epub 2021 Oct 29.
4
Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.高剂量孕激素治疗对年轻早期分化子宫内膜样腺癌患者的疗效及长期结局的影响。
Arch Gynecol Obstet. 2012 Feb;285(2):473-8. doi: 10.1007/s00404-011-1959-x. Epub 2011 Jun 25.
5
Fertility-Sparing Treatment in Young Patients With Grade 2 Presumed Stage IA Endometrioid Endometrial Adenocarcinoma.年轻的假定为IA期2级子宫内膜样腺癌患者的保留生育功能治疗
Front Oncol. 2020 Aug 25;10:1437. doi: 10.3389/fonc.2020.01437. eCollection 2020.
6
Conservative treatment with progestin and pregnancy outcomes in endometrial cancer.子宫内膜癌中孕激素保守治疗与妊娠结局
Int J Gynecol Cancer. 2009 Aug;19(6):1068-73. doi: 10.1111/IGC.0b013e3181aae1fb.
7
A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women.一项前瞻性研究显示,对于年轻女性的分化良好型子宫内膜样癌和非典型增生,在宫腔镜刮宫术后使用甲羟孕酮进行生育保留治疗。
Arch Gynecol Obstet. 2013 Nov;288(5):1115-23. doi: 10.1007/s00404-013-2826-8. Epub 2013 May 5.
8
Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.保留生育功能手术治疗非典型增生和子宫内膜癌的宫腔镜切除术:安全性与有效性
J Minim Invasive Gynecol. 2015 Nov-Dec;22(7):1178-82. doi: 10.1016/j.jmig.2015.06.004. Epub 2015 Jun 16.
9
Comparison of dilatation & curettage and endometrial aspiration biopsy accuracy in patients treated with high-dose oral progestin plus levonorgestrel intrauterine system for early-stage endometrial cancer.大剂量孕激素口服联合左炔诺孕酮宫内缓释系统治疗早期子宫内膜癌患者中,扩宫刮宫术与子宫内膜吸取活检术的准确性比较。
Gynecol Oncol. 2013 Sep;130(3):470-3. doi: 10.1016/j.ygyno.2013.06.035. Epub 2013 Jun 30.
10
Conservative management of young patients with endometrial highly-differentiated adenocarcinoma.年轻子宫内膜高分化腺癌患者的保守治疗
J Obstet Gynaecol. 2011;31(1):13-7. doi: 10.3109/01443615.2010.532249.

引用本文的文献

1
Fertility-preserving treatment in patients with early-stage endometrial cancer: A protocol for systematic review and meta-analysis.早期子宫内膜癌患者的生育力保留治疗:一项系统评价与荟萃分析方案
Medicine (Baltimore). 2021 Dec 3;100(48):e27961. doi: 10.1097/MD.0000000000027961.
2
Chances of pregnancy and live birth among women undergoing conservative management of early-stage endometrial cancer: a systematic review and meta-analysis.早期子宫内膜癌保守治疗女性的妊娠和活产几率:系统评价和荟萃分析。
Hum Reprod Update. 2022 Feb 28;28(2):282-295. doi: 10.1093/humupd/dmab041.
3
Weight control is vital for patients with early-stage endometrial cancer or complex atypical hyperplasia who have received progestin therapy to spare fertility: a systematic review and meta-analysis.

本文引用的文献

1
Fertility-sparing management of endometrial adenocarcinoma.子宫内膜腺癌的保留生育力治疗。
Obstet Gynecol Surv. 2011 Jul;66(7):443-51. doi: 10.1097/OGX.0b013e31822f8f66.
2
Pregnancy outcome in patients with stage 1a endometrial adenocarcinoma, who conservatively treated with megestrol acetate.接受醋酸甲地孕酮保守治疗的 1a 期子宫内膜腺癌患者的妊娠结局。
Arch Gynecol Obstet. 2012 Mar;285(3):791-5. doi: 10.1007/s00404-011-2021-8. Epub 2011 Jul 30.
3
Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
对于接受孕激素治疗以保留生育能力的早期子宫内膜癌或复杂性非典型增生患者而言,体重控制至关重要:一项系统评价与荟萃分析。
Cancer Manag Res. 2019 May 6;11:4005-4021. doi: 10.2147/CMAR.S194607. eCollection 2019.
4
Efficacy of doxorubicin after progression on carboplatin and paclitaxel in advanced or recurrent endometrial cancer: a retrospective analysis of patients treated at the Brazilian National Cancer Institute (INCA).多柔比星在晚期或复发性子宫内膜癌患者中顺铂和紫杉醇进展后的疗效:巴西国家癌症研究所(INCA)治疗患者的回顾性分析。
Med Oncol. 2018 Jan 31;35(3):20. doi: 10.1007/s12032-018-1086-7.
5
Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia.高分化早期子宫内膜癌和复杂性不典型增生保留生育功能治疗方法的比较。
Oncotarget. 2017 May 3;8(34):57642-57653. doi: 10.18632/oncotarget.17588. eCollection 2017 Aug 22.
6
Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: A meta-analysis and systematic review.早期子宫内膜癌和非典型复杂性增生患者保留生育功能治疗的比较:一项荟萃分析与系统评价
Medicine (Baltimore). 2017 Sep;96(37):e8034. doi: 10.1097/MD.0000000000008034.
高剂量孕激素治疗对年轻早期分化子宫内膜样腺癌患者的疗效及长期结局的影响。
Arch Gynecol Obstet. 2012 Feb;285(2):473-8. doi: 10.1007/s00404-011-1959-x. Epub 2011 Jun 25.
4
Prolonged conservative treatment of endometrial cancer patients: more than 1 pregnancy can be achieved.对子宫内膜癌患者进行长期保守治疗:超过 1 次妊娠是可以实现的。
Int J Gynecol Cancer. 2011 Jan;21(1):72-8. doi: 10.1097/IGC.0b013e31820003de.
5
Progestogen treatment options for early endometrial cancer.孕激素治疗早期子宫内膜癌的选择。
BJOG. 2010 Jun;117(7):879-84. doi: 10.1111/j.1471-0528.2010.02552.x. Epub 2010 Apr 12.
6
Efficacy of megestrol acetate (megace) in the treatment of patients with early endometrial adenocarcinoma: our experiences with 21 patients.醋酸甲地孕酮(美可治)治疗早期子宫内膜腺癌患者的疗效:我们对21例患者的经验。
Int J Gynecol Cancer. 2009 Feb;19(2):249-52. doi: 10.1111/IGC.0b013e31819c5372.
7
Progression of atypical endometrial hyperplasia to adenocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intrauterine system.尽管使用左炔诺孕酮宫内节育系统进行宫内孕激素治疗,非典型子宫内膜增生仍进展为腺癌。
Obstet Gynecol. 2008 Feb;111(2 Pt 2):547-9. doi: 10.1097/01.AOG.0000300716.84819.c6.
8
Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.醋酸甲羟孕酮用于年轻女性子宫内膜癌和非典型增生保留生育功能治疗的多中心II期研究。
J Clin Oncol. 2007 Jul 1;25(19):2798-803. doi: 10.1200/JCO.2006.08.8344.
9
Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.用孕激素治疗的子宫内膜增生和高分化癌的组织学改变。
Am J Surg Pathol. 2007 Jul;31(7):988-98. doi: 10.1097/PAS.0b013e31802d68ce.
10
Young patients with endometrial carcinoma selected for conservative treatment: a need for vigilance for synchronous ovarian carcinomas, case report and literature review.选择接受保守治疗的年轻子宫内膜癌患者:需警惕同时性卵巢癌,病例报告及文献综述
Gynecol Oncol. 2007 Mar;104(3):757-60. doi: 10.1016/j.ygyno.2006.11.013. Epub 2007 Jan 9.